Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» inflammatory bowel disease
inflammatory bowel disease
Surrozen stops IBD program due to dose concerns and competition
Fierce Biotech
Thu, 01/18/24 - 11:18 am
Surrozen
inflammatory bowel disease
SZN-1326
clinical trials
Can This Tiny Biotech Take On Pfizer?
Motley Fool
Tue, 09/20/22 - 10:19 am
Prometheus Biosciences
Pfizer
inflammatory bowel disease
PRA023
Prometheus takes on Pfizer in inflammatory bowel diseases
EP Vantage
Fri, 09/16/22 - 10:11 am
Prometheus Biosciences
Pfizer
PF-06480605
PRA023
inflammatory bowel disease
Finch Therapeutics Regains Rights to Two Takeda-Owned IBD Drugs
BioSpace
Fri, 08/26/22 - 10:41 am
Takeda
Finch Therapeutics
FIN-524
FIN-525
inflammatory bowel disease
GentiBio partners with Bristol Myers as cell therapy for immune disease gain momentum
BioPharma Dive
Wed, 08/10/22 - 10:46 am
GentiBio
Bristol Myers Squibb
cell therapy
inflammatory bowel disease
Celsius turns up the heat with lead drug selection, $83M financing
Fierce Biotech
Thu, 03/24/22 - 10:55 am
Celsius Therapeutics
inflammatory bowel disease
CEL383
funding
GlaxoSmithKline joins Sosei's who's-who list of clients with global licensing pact for IBD small molecules
Endpoints
Sun, 12/20/20 - 11:02 pm
Sosei Heptares
GSK
inflammatory bowel disease
Gilead downsizes multibillion-dollar deal once at center of CEO's rebuild
Bizjournals
Tue, 12/15/20 - 08:31 pm
Gilead Sciences
Galapagos
clinical trials
filgotinib
rheumatoid arthritis
inflammatory bowel disease
Boehringer Ingelheim adds second AI partner in a month
Endpoints
Wed, 05/6/20 - 12:14 pm
Boehringer Ingelheim
artificial intelligence
BERG
Bayesian AI
biomarkers
Crohn's Disease
inflammatory bowel disease
Takeda pens Prometheus pact to find novel IBD targets
Fierce Biotech
Fri, 10/4/19 - 10:30 am
Takeda
inflammatory bowel disease
R&D
Promethera Biosciences
Hunting better biomarkers, J&J taps Celsius to unpack role played by single cells
Biopharma Dive
Tue, 07/9/19 - 11:55 am
JNJ
Celsius Therapeutics
biomarkers
inflammatory bowel disease
Takeda’s Entyvio Ad Captures Struggle to Make Plans
Xtalks
Mon, 05/6/19 - 10:52 am
Takeda
DTC ads
inflammatory bowel disease
Entyvio
Synlogic Achieves Milestone in Development of Synthetic Biotic for IBD
CP Wire
Thu, 03/7/19 - 10:28 am
Synlogic
inflammatory bowel disease
AbbVie
Synlogic Achieves Milestone in Development of Synthetic Biotic for IBD
Thu, 03/7/19 - 10:05 am
Synlogic
inflammatory bowel disease
AbbVie
Takeda is ready to auction off a PhIII favorite at Shire to clear the last hurdles to a $62B buyout
Enpoints
Sun, 10/28/18 - 07:47 pm
Takeda
Shire
inflammatory bowel disease
IBD
ulcerative colitis
Crohn's Disease
M&A
SHP647
Microbiome startup Nextbiotix raises €7M to tackle inflammatory bowel diseases
Fierce Biotech
Thu, 07/5/18 - 10:24 pm
Nextbiotix
inflammatory bowel disease
IBD
microbiome
Gilead and Alphabet's Verily to Collaborate on Research in Immunological and Molecular Drivers of Inflammatory Diseases
CP Wire
Mon, 04/30/18 - 09:08 pm
Gilead Sciences
Verily
Immunoscape
lupus
rheumatoid arthritis
inflammatory bowel disease
CytoReason Cements Proof-of-Concept with Machine-Learning-Facilitated Biomarker Breakthrough in Inflammatory Bowel Disease
CP Wire
Mon, 04/16/18 - 04:18 pm
CytoReason
IBD
inflammatory bowel disease
biomarkers
Can Johnson & Johnson Replace Remicade for $100 Million Upfront?
Motley Fool
Wed, 02/21/18 - 09:40 am
JNJ
Remicade
TD-1473
Theravance
JAK inhibitors
inflammatory bowel disease
With help from J&J, upstart Provention lands rights to two mid-stage IBD drugs and shoots for PhII
Endpoints
Thu, 09/21/17 - 08:49 am
JNJ
Provention Bio
IBD
inflammatory bowel disease
PRV-6527
Crohn's Disease
PRV-300
ulcerative colitis
Pages
1
2
next ›
last »